Christiane Amendt

USPTO Granted Patents = 25 (Patent Applications = 5)

CIPO Patents = 9 (Patent Applications = 3)

EPO Patents = 17 (Patent Applications = 12)

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 128(Granted Patents)

Location History:

Darmstadt, DE (2009 - 2013)
Muehltal/Trautheim, DE (2011 - 2019)

Company Filing History:

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

Years Active: 2009-2019

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10478501 - Method of treating disorders using a pharmaceutical composition of oligopeptides (2019-11-19),

2. 9382244 - 7-azaindole-2,7-naphthyridine derivative for the treatment of tumours (2016-07-05),

3. 9051318 - Pyrido [2, 3-B] pyrazine compounds and their therapeutical uses such as for inhibiting ATP consuming proteins and treating diseases associated therewith (2015-06-09),

4. 9051307 - Bipyridyl derivatives (2015-06-09),

5. 8987301 - Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors (2015-03-24),

6. 8912216 - Hetaryl-[1,8]naphthyridine derivatives (2014-12-16),

7. 8846931 - Bipyridyl derivatives (2014-09-30),

8. 8815893 - Hetarylaminonaphthyridines (2014-08-26),

9. 8791113 - 2,4-diaryl-substituted [1,8] naphthyridines as kinase inhibitors for use against cancer (2014-07-29),

10. 8614226 - Hetaryl-[1,8]naphthyridine derivatives (2013-12-24),

11. 8524732 - Substituted tetrahydroquinolines (2013-09-03),

12. 8410143 - Methylene urea derivatives (2013-04-02),

13. 8207345 - Tetrahydroquinolines for use as modulators of the mitotic motor protein Eg5 (2012-06-26),

14. 8202882 - 5-cyanothienopyridines for the treatment of tumours (2012-06-19),

15. 8110583 - Tetrahydroquinoline derivatives (2012-02-07),

Title: Christiane Amendt: Innovator in Pharmaceutical Patents

Introduction: Christiane Amendt is a prolific inventor based in Muehltal/Trautheim, Germany, with an impressive portfolio of 25 patents to her name. Her work primarily focuses on pharmaceutical compositions that address various health concerns, showcasing her dedication to innovation in the medical field.

Latest Patents: Among her most recent patents, Christiane has developed a method for treating disorders using a pharmaceutical composition of oligopeptides. This invention involves a unique combination of lipophilic and/or amphiphilic compounds, which are key ingredients in formulating effective pharmaceutical compositions. Additionally, she has created a 7-azaindole-2,7-naphthyridine derivative aimed at the treatment of tumors. This compound, specifically 4-(2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-2,7-naphthyridin-1-ylamine, offers promising therapeutic potential against tumor growth, metastasis, and even AIDS.

Career Highlights: Christiane has significantly contributed to her field while working at renowned companies such as Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. Her extensive experience in these organizations highlights her expertise in patent development and her commitment to advancing pharmaceutical innovations.

Collaborations: Throughout her career, Christiane has collaborated with notable colleagues such as Frank Zenke and Dirk Finsinger. These collaborations have allowed her to blend diverse ideas and proffer unique solutions within her research and development activities.

Conclusion: With 25 patents and groundbreaking inventions in the pharmaceutical industry, Christiane Amendt stands out as a leading innovator. Her contributions significantly impact the treatment of complex health issues, and her work continues to inspire progress in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.